FOLH1 and neoplasm: The cumulative amounts of anti-PSMA/anti-CD3 (scFv-Fab and Fab-scFv) BsAb-armed T cells in the tumor tissues were, respectively, 13.7 and 18.4 times higher than that of the OKT3- T cells (Fig. 5J–K).